Inactivation of the Mouse Huntington's Disease Gene Homolog Hdh
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is a dominant neurodegenerative disorder caused by expansion of a CAG repeat in the gene encoding huntingtin, a protein of unknown function. To distinguish between "loss of function" and "gain of function" models of HD, the murine HD homolog Hdh was inactivated by gene targeting. Mice heterozygous for Hdh inactivation were phenotypically normal, whereas homozygosity resulted in embryonic death. Homozygotes displayed abnormal gastrulation at embryonic day 7.5 and were resorbing by day 8.5. Thus, huntingtin is critical early in embryonic development, before the emergence of the nervous system. That Hdh inactivation does not mimic adult HD neuropathology suggests that the human disease involves a gain of function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
In the citing paper
“Similar to α-syn in PD and Tau in AD, polyQ-HTT aggregates exert toxic gain-of-function effects, forming β-sheet-rich structures that disrupt essential cellular pathways and cause neurotoxicity [169,170].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [169]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Self-citationVerkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Self-citationAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., & Mulligan, R. C. (1991) · Cell · doi:10.1016/0092-8674(91)90011-m · Cited by 1,281
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,035
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749
Self-citationDNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
Research works printed but not linked: 3
- CELL 78: 23 (1994).
- Nagy, A., Gene Targeting: A Practical Approach: 147 (1993).
- Wurst, W., Gene Targeting: A Practical Approach: 31 (1993).
Cited by
Items 201–300 of 885
Aberrant amplification of A 2A receptor signaling in striatal cells expressing mutant huntingtin
Varani, K., Rigamonti, D., Sipione, S., Camurri, A., Borea, P. A., Cattabeni, F., Abbracchio, M. P., & Cattaneo, E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0730fje · Cited by 91
Huntington's disease: translating a CAG repeat into a pathogenic mechanism
MacDonald, M. E., & Gusella, J. F. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80097-3 · Cited by 102
Self-citationBezprozvanny, I. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0393-y · Cited by 91
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
Pla, P., Orvoen, S., Saudou, F., David, D. J., & Humbert, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00135 · Cited by 91
Moulder, K. L., Onodera, O., Burke, J. R., Strittmatter, W. J., & Johnson, E. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00705.1999 · Cited by 94
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
Metzger, S., Rong, J., Nguyen, H.-P., Cape, A., Tomiuk, J., Soehn, A. S., Propping, P., Freudenberg-Hua, Y., Freudenberg, J., Tong, L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn003 · Cited by 88
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040754 · Cited by 99
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 98
Huntingtin: Here, There, Everywhere!
Sousa, C. M., & Humbert, S. (2013) · Journal of Huntington s Disease · doi:10.3233/jhd-130082 · Cited by 97
Polyglutamine expansion in huntingtin alters its interaction with phospholipids
Kegel, K. B., Sapp, E., Alexander, J., Valencia, A., Reeves, P., Li, X., Masso, N., Sobin, L., Aronin, N., & DiFiglia, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06255.x · Cited by 93
Mechanics of head fold formation: investigating tissue-level forces during early development
Varner, V. D., Voronov, D. A., & Taber, L. A. (2010) · Development · doi:10.1242/dev.054387 · Cited by 96
Kay, C., Collins, J. A., Skotte, N. H., Southwell, A. L., Warby, S. C., Caron, N. S., Doty, C. N., Nguyen, B., Griguoli, A., Ross, C. J., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.128 · Cited by 88
Neurons Lacking Huntingtin Differentially Colonize Brain and Survive in Chimeric Mice
Reiner, A., Del Mar, N., Meade, C. A., Yang, H., Dragatsis, I., Zeitlin, S., & Goldowitz, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07608.2001 · Cited by 69
Is the ubiquitin-proteasome system impaired in Huntington’s disease?
Ortega, Z., Díaz-Hernández, M., & Lucas, J. J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7222-8 · Cited by 95
A Putative Drosophila Homolog of the Huntington's Disease Gene
Li, Z., Karlovich, C. A., Fish, M. P., Scott, M. P., & Myers, R. M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1807 · Cited by 82
Baldo, B., Weiss, A., Parker, C. N., Bibel, M., Paganetti, P., & Kaupmann, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294801 · Cited by 93
Lu, B., & Palacino, J. (2013) · The FASEB Journal · doi:10.1096/fj.12-219220 · Cited by 88
Arteaga-Bracho, E. E., Gulinello, M., Winchester, M. L., Pichamoorthy, N., Petronglo, J. R., Zambrano, A. D., Inocencio, J., De Jesus, C. D., Louie, J. O., Gokhan, S., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.09.006 · Cited by 79
Ishiguro, H., Yamada, K., Sawada, H., Nishii, K., Ichino, N., Sawada, M., Kurosawa, Y., Matsushita, N., Kobayashi, K., Goto, J., et al. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1153 · Cited by 91
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103719 · Cited by 90
“However, the HTT gene is ubiquitously expressed [85] and in HD there are important dysfunctions occurring outside the brain.”
BackgroundTarditi, A., Camurri, A., Varani, K., Borea, P. A., Woodman, B., Bates, G., Cattaneo, E., & Abbracchio, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.014 · Cited by 77
Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
Morigaki, R., & Goto, S. (2017) · Brain Sciences · doi:10.3390/brainsci7060063 · Cited by 77
Rao, D. S., Chang, J. C.-C., Kumar, P. D., Mizukami, I. F., Smithson, G. M., Bradley, S. V., Parlow, A. F., & Ross, T. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7796-7806.2001 · Cited by 89
Wood, J. D., MacMillan, J. C., Harper, P. S., Lowenstein, P. R., & Jones, A. L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.481 · Cited by 89
Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors
Futter, M., Diekmann, H., Schoenmakers, E., Sadiq, O., Chatterjee, K., & Rubinsztein, D. C. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066399 · Cited by 73
Barron, J. C., Hurley, E. P., & Parsons, M. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.689332 · Cited by 85
Emerging Roles of Exosomes in Huntington’s Disease
Ananbeh, H., Vodicka, P., & Kupcova Skalnikova, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084085 · Cited by 82
Multiple Aspects of Gene Dysregulation in Huntington’s Disease
Moumné, L., Betuing, S., & Caboche, J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00127 · Cited by 77
Modeling Huntington's Disease in Cells, Flies, and Mice
Cattaneo, E. F., & Sipione, S. (2001) · Molecular Neurobiology · doi:10.1385/mn:23:1:21 · Cited by 85
The Ubiquitin-Proteasome Pathway in Huntington's Disease
Mitra, S. S., & Finkbeiner, S. M. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.60 · Cited by 84
Genes involved in hereditary ataxias
Klockgether, T. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01315-0 · Cited by 83
Sawant, N. A., Morton, H., Kshirsagar, S., Reddy, A. P., & Reddy, P. H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02556-x · Cited by 83
Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
Li, X.-J., Chang, R., Liu, X., & Li, S. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s58470 · Cited by 62
Tong, Y., Ha, T. J., Liu, L., Nishimoto, A., Reiner, A., & Goldowitz, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2774-11.2011 · Cited by 67
Oligonucleotide therapeutics in neurodegenerative diseases
Scoles, D. R., & Pulst, S. M. (2018) · RNA Biology · doi:10.1080/15476286.2018.1454812 · Cited by 81
Leavitt, B. R., Kordasiewicz, H. B., & Schobel, S. A. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0299 · Cited by 71
RNAi medicine for the brain: progresses and challenges
Boudreau, R. L., Rodríguez-Lebrón, E., & Davidson, B. L. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr137 · Cited by 80
Li, S.-H., Hosseini, S. H., Gutekunst, C., Hersch, S. M., Ferrante, R. J., & Li, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19220 · Cited by 80
Huntingtin: a single bait hooks many species
Gusella, J. F., & MacDonald, M. E. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80071-8 · Cited by 80
Self-citationAltered Cholesterol Homeostasis in Huntington’s Disease
Kacher, R., Mounier, C., Caboche, J., & Betuing, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.797220 · Cited by 70
Transgenic models of Huntington'sdisease
Sathasivam, K., Hobbs, C., Mangiarini, L., Mahal, A., Turmaine, M., Doherty, P., Davies, S. W., & Bates, G. P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0447 · Cited by 72
Protein misfolding inside cells: The case of huntingtin and Huntington's disease
Hatters, D. M. (2008) · IUBMB Life · doi:10.1002/iub.111 · Cited by 68
Derivation of Huntington's Disease-Affected Human Embryonic Stem Cell Lines
Bradley, C. K., Scott, H. A., Chami, O., Peura, T. T., Dumevska, B., Schmidt, U., & Stojanov, T. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0120 · Cited by 78
TRINUCLEOTIDE INSTABILITY: A Repeating Theme in Human Inherited Disorders
Gusella, J. F., & MacDonald, M. E. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.201 · Cited by 78
Self-citationMembrane trafficking in neuronal maintenance and degeneration
Wang, D., Chan, C., Cherry, S., & Hiesinger, P. R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1201-4 · Cited by 77
Hemachandra Reddy, P., Charles, V., Williams, M., Miller, G., Whetsell, W. O., & Tagle, D. A. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0456 · Cited by 72
Deficiency of Huntingtin Has Pleiotropic Effects in the Social Amoeba Dictyostelium discoideum
Myre, M. A., Lumsden, A. L., Thompson, M. N., Wasco, W., MacDonald, M. E., & Gusella, J. F. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002052 · Cited by 76
Self-citationIsmailoglu, I., Chen, Q., Popowski, M., Yang, L., Gross, S. S., & Brivanlou, A. H. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.04.005 · Cited by 72
HD CAG-correlated gene expression changes support a simple dominant gain of function
Jacobsen, J. C., Gregory, G. C., Woda, J. M., Thompson, M. N., Coser, K. R., Murthy, V., Kohane, I. S., Gusella, J. F., Seong, I. S., MacDonald, M. E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr195 · Cited by 76
Self-citationHuntington's disease gene product, huntingtin, associates with microtubules in vitro
Tukamoto, T., Nukina, N., Ide, K., & Kanazawa, I. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00205-2 · Cited by 76
Caspases in Huntington’s Disease
Sanchez-Mejia, R. O., & Friedlander, R. M. (2001) · The Neuroscientist · doi:10.1177/107385840100700604 · Cited by 76
Toward Understanding the Molecular Pathology of Huntington's Disease
Wellington, C. L., Brinkman, R. R., O'Kusky, J. R., & Hayden, M. R. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00897.x · Cited by 72
Micro RNA -214,-150,-146a and-125b target Huntingtin gene
Sinha, M., Ghose, J., & Bhattarcharyya, N. P. (2011) · RNA Biology · doi:10.4161/rna.8.6.16035 · Cited by 75
Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
Department of Pharmacology, C. O. P. A. P. S., & Sari, Y. (2011) · International Journal of Biomedical Science · doi:10.59566/ijbs.2011.7089 · Cited by 61
Transgenic Mice in the Study of Polyglutamine Repeat Expansion Diseases
Bates, G. P., Mangiarini, L., & Davies, S. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00196.x · Cited by 75
Modeling Huntington's disease with induced pluripotent stem cells
Kaye, J. A., & Finkbeiner, S. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.02.005 · Cited by 65
Dietrich, P., Shanmugasundaram, R., E, S., & Dragatsis, I. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn324 · Cited by 58
Siebzehnrübl, F. A., Raber, K. A., Urbach, Y. K., Schulze-Krebs, A., Canneva, F., Moceri, S., Habermeyer, J., Achoui, D., Gupta, B., Steindler, D. A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807962115 · Cited by 63
Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
Takeuchi, T., & Nagai, Y. (2017) · Brain Sciences · doi:10.3390/brainsci7100128 · Cited by 71
“A study using knock-out mice also demonstrated that heterozygous disruption of Hdh gene, a mouse homologue of human huntingtin gene, did not show apparent disease phenotypes, while homozygous disruption resulted in embryonic lethality, indicating that huntingtin has essential roles in the embryonic development, and lo…”
BackgroundHuntington's disease: CAG genetics expands neurobiology
Gusella, J. F., & MacDonald, M. E. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80072-7 · Cited by 71
Self-citationKosinski, C. M., Cha, J.-H. J., Young, A. B., Persichetti, F., MacDonald, M. E., Gusella, J. F., Penney, J. B., & Standaert, D. G. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6441 · Cited by 71
Self-citationRandom Mutagenesis Screen for Dominant Behavioral Mutations in Mice
Nolan, P. M., Kapfhamer, D., & Bućan, M. (1997) · Methods · doi:10.1006/meth.1997.0545 · Cited by 67
Blockx, I., Groof, G. D., Verhoye, M., Audekerke, J. V., Raber, K. A., Poot, D. H. J., Sijbers, J., Osmand, A. P., von Hörsten, S., & der Linden, A. V. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.062 · Cited by 70
Van Raamsdonk, J. M., Pearson, J., Murphy, Z., Hayden, M. R., & Leavitt, B. R. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-80 · Cited by 61
Miller, B., & Борисович, Б. И. (2010) · Future Neurology · doi:10.2217/fnl.10.41 · Cited by 69
The use of transgenic and knock-in mice to study Huntington’s disease
Hickey, M. A., & Chesselet, M.-F. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072863 · Cited by 69
Huntington disease: new insights into the relationship between CAG expansion and disease
Nasir, J., Goldberg, Y. P., & Hayden, M. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1431 · Cited by 69
Woda, J. M., Calzonetti, T., Hilditch-Maguire, P., Duyao, M. P., Conlon, R. A., & MacDonald, M. E. (2005) · BMC Developmental Biology · doi:10.1186/1471-213x-5-17 · Cited by 68
Self-citationRodan, L. H., Cohen, J. S., Fatemi, A. S., Gillis, T., Lucente, D. E., Gusella, J. F., & Picker, J. D. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.74 · Cited by 68
Self-citationZebrafish and Medaka: Important Animal Models for Human Neurodegenerative Diseases
Wang, J., & Cao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910766 · Cited by 67
Rückle, T., Biamonte, M. A., Grippi-Vallotton, T., Arkinstall, S., Cambet, Y., Camps, M., Chabert, C., Church, D. J., Halazy, S., Jiang, X., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031112e · Cited by 67
Butler, D. C., Mclear, J., & Messer, A. (2011) · Progress in neurobiology · doi:10.1016/j.pneurobio.2011.11.004 · Cited by 59
Gene therapy for Huntington's disease
Ramaswamy, S., & Kordower, J. H. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.030 · Cited by 57
Biagioli, M., Ferrari, F., Mendenhall, E. M., Zhang, Y., Erdin, S., Vijayvargia, R., Vallabh, S. M., Solomos, N., Manavalan, P., Ragavendran, A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv006 · Cited by 65
Self-citationDNA vaccination against mutant huntingtin ameliorates the HDR6/2 diabetic phenotype
Miller, T. W., Shirley, T. L., Wolfgang, W. J., Kang, X., & Messer, A. C. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00063-7 · Cited by 65
Selective Roles of Normal and Mutant Huntingtin in Neural Induction and Early Neurogenesis
Nguyen, G. D., Gökhan, Ş., Molero, A. E., & Mehler, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064368 · Cited by 64
Huntington’s disease and striatal signaling
Roze, E. F., Cahill, E., Martin, E., Bonnet, C., Vanhoutte, P., Betuing, S., & Caboche, J. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00055 · Cited by 64
Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases
Kolli, N., Lü, M., Maiti, P., Rossignol, J., & Dunbar, G. L. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.07.007 · Cited by 64
Transgenic and knockout databases
Anagnostopoulos, A. V., Mobraaten, L. E., Sharp, J. J., & Davisson, M. T. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00525-x · Cited by 64
Personalized gene silencing therapeutics for Huntington disease
Kay, C., Skotte, N. H., Southwell, A. L., & Hayden, M. R. (2014) · Clinical Genetics · doi:10.1111/cge.12385 · Cited by 63
Nakao, N., & Itakura, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00058-1 · Cited by 63
Bolivar, V. J., MANLEY, K. M., & Messer, A. C. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1233 · Cited by 63
Brandstaetter, H., Kruppa, A. J., & Buss, F. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017368 · Cited by 52
Is Huntingtin Dispensable in the Adult Brain?
Liu, J.-P., & Zeitlin, S. O. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170235 · Cited by 62
Clabough, E. B. D., & Zeitlin, S. O. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi477 · Cited by 52
Szlachcic, W. J., Switonski, P. M., Krzyżosiak, W. J., Figlerowicz, M., & Figiel, M. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019406 · Cited by 61
Fraser, A. G., McCarthy, N., & Evan, G. I. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80011-0 · Cited by 61
Huntingtin Mediates Anxiety/Depression-Related Behaviors and Hippocampal Neurogenesis
Ben M'Barek, K., Pla, P., Orvoen, S., Benstaali, C., Godin, J. D., Gardier, A. M., Saudou, F., David, D. J., & Humbert, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5110-12.2013 · Cited by 47
Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival
Burrus, C. J., McKinstry, S. U., Kim, N., Ozlu, M. I., Santoki, A., Fang, F. Y., Ma, A., Karadeniz, Y. B., Worthington, A. K., Dragatsis, I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.069 · Cited by 60
Differential distribution of the normal and mutated forms of huntingtin in the human brain
Gourfinkel‐An, I., Cancel, G., Trottier, Y., Devys, D., Tora, L., Lutz, Y., Imbert, G., Saudou, F., Stevanin, G., Agid, Y., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420507 · Cited by 54
Selective neuronal requirement for huntingtin in the developing zebrafish
Henshall, T. L., Tucker, B., Lumsden, A. L., Nornes, S., Lardelli, M. T., & Richards, R. I. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp455 · Cited by 59
Roze, E. F., Bonnet, C., Bétuing, S., & Caboche, J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_5 · Cited by 59
Miller, T. W., Zhou, C., Ginés, S., MacDonald, M. E., Mazarakis, N. D., Bates, G. P., Huston, J. S., & Messer, A. C. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.003 · Cited by 59
Self-citationMolecular aspects of Huntington's disease
Walling, H. W., Baldassare, J. J., & Westfall, T. C. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981101)54:3<301::aid-jnr1>3.0.co;2-w · Cited by 59
Lee, C. Y. D., Cantle, J. P., & Yang, X. W. (2013) · The FEBS Journal · doi:10.1111/febs.12418 · Cited by 56
Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II
Edwardson, J. M., Wang, C.-T., Gong, B., Wyttenbach, A., Bai, J., Jackson, M. B., Chapman, E. R., & Morton, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304615200 · Cited by 52
The therapeutic potential of siRNA in gene therapy of neurodegenerative disorders
Koutsilieri, E., Rethwilm, A., & Scheller, C. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_7 · Cited by 57
Askeland, G., Dosoudilova, Z., Rodinova, M., Klempir, J., Liskova, I., Kuśnierczyk, A., Bjørås, M., Nesse, G., Klungland, A., Hansikova, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27985-y · Cited by 54
Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts?
Rubinsztein, D. C., Wyttenbach, A., & Rankin, J. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.4.265 · Cited by 57
Stem cell‐based therapy for Huntington's disease
Maucksch, C., Vazey, E. M., Gordon, R. J., & Connor, B. J. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24432 · Cited by 56
Metadata
- Authors
- Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Mount Sinai Hospital (CA)
- Corresponding author
- MacDonald, Marcy E.
- Venue
- Science
- Published
- 1995-07-21
- Volume
- 269
- Issue
- 5222
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2002644780
- Cited by
- 723
- References
- 29
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 15 · 2023: 16 · 2022: 18 · 2021: 26 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 20 · 2015: 21 · 2014: 33 · 2013: 22 · 2012: 32
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 16367, NS32765, R01NS032765)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- Huntington's disease, huntingtin, gene targeting, embryonic lethality, gastrulation, loss of function, gain-of-function, CAG repeat expansion, mouse model, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Base Sequence, Cell Line, Ectoderm, Female, Embryonic and Fetal Development, Genotype, Heterozygote, Homozygote, Humans, Huntington Disease, Male, Mesoderm, Mice, Inbred C57BL, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Phenotype, Stem Cells, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.